Pre-eclampsia: 3rd Trimester Screening
It's time to implement it: 3rd Trimester Pre-eclampsia Screening
Screening for late-onset pre-eclampsia using sFlt-1 and PlGF now available
Late onset pre-eclampsia represents 75% of all pre-eclampsia cases and is associated with significant maternal mortality and morbidity.
While screening and aspirin administration in the first trimester can help prevent early onset pre-eclampsia, there is still a pressing need for better methods to predict and prevent late onset cases.
Screening at week 35-36 using PlGF and sFlt-1 allows to detect late-onset pre-eclampsia, opening the door to a prevention with timed birth. Developed by the Fetal Medicine Foundation, this screening concept is now available with B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR, offering healthcare professionals an important tool for identifying and managing at-risk pregnancies.
For further insights into this crucial topic, be sure to check out some of the most important publications in the field: Literature Review - 3rd Trimester Pre-eclampsia Screening (378 KB).
Video about Prediction of pre-eclampsia in 3rd trimester: Tune in to hear from the esteemed opinion leader, Professor Kypros Nicolaides, as he shares the latest scientific insights on predicting pre-eclampsia in the third trimester. Don't miss out on the opportunity to learn from this renowned expert in the field.
Do you want to learn more about the screening concept mentioned above, or speak with a sales representative to explore how it could benefit your practice or patients? We would love to hear from you! Please don't hesitate to contact us for further information and support.